Rigel Pharmaceuticals Inc SEC filings RIGL

Rigel Pharmaceuticals Inc has 1,002 filings in SEC EDGAR's recent list, going back to Nov 6, 2007. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 3, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
10-K Annual report Mar 4, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 10, 2024 Dec 31, 2023
10-K Annual report Mar 5, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 14, 2023 Dec 31, 2022
10-K Annual report Mar 7, 2023 Dec 31, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
10-K Annual report Mar 2, 2021 Dec 31, 2020
10-K Annual report Feb 27, 2020 Dec 31, 2019
10-K Annual report Feb 28, 2019 Dec 31, 2018
10-K/A Amended annual report Mar 29, 2018 Dec 31, 2017
10-K Annual report Mar 6, 2018 Dec 31, 2017
10-K Annual report Mar 7, 2017 Dec 31, 2016
10-K Annual report Mar 8, 2016 Dec 31, 2015
10-K Annual report Mar 3, 2015 Dec 31, 2014
10-K Annual report Mar 4, 2014 Dec 31, 2013
10-K Annual report Mar 5, 2013 Dec 31, 2012
ARS Annual report to shareholders Apr 23, 2012 Dec 31, 2011
10-K Annual report Mar 6, 2012 Dec 31, 2011
ARS Annual report to shareholders Apr 5, 2011 Dec 31, 2010
10-K Annual report Mar 1, 2011 Dec 31, 2010
ARS Annual report to shareholders Apr 13, 2010 Dec 31, 2009
10-K Annual report Mar 2, 2010 Dec 31, 2009
ARS Annual report to shareholders Apr 16, 2009 Dec 31, 2008
10-K Annual report Feb 27, 2009 Dec 31, 2008
10-K Annual report Mar 7, 2008 Dec 31, 2007

Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RIGL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Accelerated filer
SEC CIK
1034842
Former names
RIGEL PHARMACEUTICALS INC (until Nov 5, 2026)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.